Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon

Fig. 1

Relapsing Remitting Multiple Sclerosis (RRMS) patients treated with glatiramer acetate (GA), January 2004 – October 2013. Flow chart showing prescription of glatiramer acetate (GA) for Relapsing Remitting Multiple Sclerosis (RRMS) patients at the Neuroimmunology and MS Unit of La Paz University Hospital, Madrid, Spain, from January 2004 to October 2013. Patients lost to follow-up, those excluded from statistical analysis and reasons for stopping GA treatment are indicated

Back to article page